Results 91 to 97 of about 429 (97)

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

New England Journal of Medicine, 2018
Dominik Dytfeld, Sebastian Grosicki, Phillipe Moreau   +2 more
exaly  

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Lancet, The, 2010
Michele Cavo, Francesca Patriarca, Lucia Pantani   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer

Ca-A Cancer Journal for Clinicians, 1999
exaly  

Acute myeloid leukemia management and research in 2025

Ca-A Cancer Journal for Clinicians
exaly  

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
exaly  

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

New England Journal of Medicine, 1999
exaly